ZCMD Zhongchao Inc.
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.…
Industry Peers
Health Information ServicesKey Statistics
About Zhongchao (NASDAQ: ZCMD)
›
Zhongchao (NASDAQ: ZCMD) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 33 employees.
The shares were at 0.8147 USD on 19 November 2026, down 99.9% over 52 weeks. Its 52-week range is 0.8030 USD to 1443.36 USD: the price is 99.9% below the high and 1.5% above the low.
Its market capitalisation is 3.61M USD.
Zhongchao reports return on equity of -33.9%, an operating margin of -147.1% and revenue down 85.0% year over year.
It holds more cash than debt, a net cash position of 17.34M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.